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Pituitary volume and the effects of phototherapy in 
patients with seasonal winter depression:  
a controlled study
Volume da pituitária e os efeitos da fototerapia em 
pacientes com depressão sazonal de inverno: um  
estudo controlado
Abstract
Objectives: Our aims were to investigate the pituitary volume in patients with seasonal winter depression and healthy volunteers in winter 
and summer, and to assess the effects of phototherapy in these patients. Method: The pituitary volume of 12 patients with winter de-
pression and 12 healthy controls, paired according gender, age and menstrual cycle, were obtained from magnetic resonance imaging 
in winter and summer. Eight patients were submitted to phototherapy (10000 vs. 2500 lux) in a double-blind crossover fashion during 
the winter, and reassessed (symptoms and magnetic resonance imaging) after treatment. Results: There were no significant differences 
in pituitary volume between controls and patients in winter or summer. Exposure to phototherapy (10000 lux) decreased the depressive 
symptoms (p = 0.004), but the glandular volume did not change (p = 0.5). However, the pituitary volume in winter showed a positive 
correlation with the severity of depression in these patients (r = 0.69, p = 0.04). Conclusions: The results suggest that neither winter 
depression nor the change of seasons is associated with significant change in the pituitary volume. Despite the fact that this study was 
performed in a tropical area, phototherapy with 10000 lux showed to be an efficient treatment in this SAD patients sample.
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Resumo
Objetivos: Nossos objetivos foram investigar o volume da pituitária em pacientes com depressão sazonal de inverno e controles sadios, 
no inverno e verão, e avaliar os efeitos da fototerapia nesses pacientes. Método: O volume da pituitária de 12 pacientes com depressão 
de inverno e 12 controles sadios, pareados quanto ao gênero, idade e fase do ciclo menstrual, foi examinado por meio de imagem por 
ressonância magnética no inverno e verão. Oito pacientes foram submetidos à fototerapia (10.000 vs 2.500 lux) de forma duplo-cega 
e cruzada durante o inverno e reavaliados (sintomas e imagem por ressonância magnética) após o tratamento. Resultados: Não houve 
diferença significativa no volume da pituitária entre controles e pacientes, no inverno e verão. A fototerapia (10.000 lux) reduziu os 
sintomas depressivos (p = 0,004), mas não alterou o volume glandular (p = 0,5). Contudo, o volume da pituitária, no inverno, mostrou 
uma correlação positiva com a gravidade da depressão nesses pacientes (r = 0,69, p = 0,04). Conclusões: Os resultados sugerem 
que nem a depressão de inverno, nem a mudança das estações estão associadas com a mudança significativa do volume da pituitária. 
Apesar do fato deste estudo ter sido realizado em uma região tropical, a fototerapia com 10.000 lux mostrou-se um tratamento eficaz 
nesta amostra.
Descritores: Hipófise; Variações sazonais; Imagem por ressonância magnética; Transtorno depressivo sazonal; Fototerapia
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Introduction 
Neuroendocrinological investigations of mental disorders have 
suggested abnormalities in pituitary function and volume.1,2 
Imaging studies of major depression have described an increase 
in the volume of the pituitary in acutely depressed patients.3,4 
These results are in agreement with functional studies showing 
hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis in 
this group of patients.5 In addition, a reversible enlargement of the 
adrenal gland, which disappears with remission of symptoms,5-7 
and an association between a failure to suppress cortisol secretion 
after dexamethasone administration and pituitary volume have also 
been reported in patients with major depression.8 
Seasonal affective disorder (SAD) was first reported in 1984 by 
a research group at the National Institute of Mental Health (NIMH) 
and included recurrent episodes of depression, hypomania or mania 
occuring in specific seasons. Winter seasonal depression occurs in 
autumn-winter and usually remits spontaneously in spring-summer.9 
It is a common condition, but its prevalence rates vary among 
different studies and countries, and it is consistently found to be 
more common in women. Its clinical picture is characterized by 
atypical depressive symptoms and response to phototherapy.9,10 Like 
antidepressant drugs, light therapy is an intervention that may act via 
serotonergic potentiation, although other mechanisms of action - in 
particular, circadian rhythm phase shifting – are likely to be involved. 
In contrast to the delayed effect typical of antidepressants, remission of 
depressive symptoms often occurs within a week of light treatment.10 
Besides that, light therapy has a low side-effect profile.11,12 
The pathophysiology of winter seasonal depression is still 
unknown.10 Interestingly, contrary to nonseasonal depression, 
neuroendocrine studies on SAD patients have shown: 1) normal 
suppression of cortisol by dexamethasone;13 2) reduction of 
adrenocorticotrophic hormone (ACTH) and cortisol response 
to corticotrophin-releasing hormone (CRH).14,15 These findings 
demonstrate hypoactivity of the HPA axis in this group of patients. 
Indeed, some investigators have suggested that atypical depressions 
comprise a pathophysiologically separated category of depressions, 
characterized by hypoactive HPA axis function.5
 Imaging studies involving patients with SAD and the effects 
of seasonality on this gland are scarce, but they suggest that 
seasonal factors could influence the pituitary size. Moul et al. 
have demonstrated the decrease in the pituitary volume in healthy 
volunteers after an experimental exposure to a short photoperiod.16 
To our knowledge, only one magnetic resonance imaging (MRI) 
study in patients with winter seasonal depression was performed, 
and it has not found significant differences in pituitary volumes in 
comparison to controls.17 However, the effects of phototherapy on 
pituitary size have not been measured before. Therefore, our aims 
were to investigate the possible variation in the pituitary size between 
controls and SAD patients during winter and summer, and to assess 
the effects of phototherapy on these patients.
Method
Twelve patients who were selected in a previous study at the 
Clinical Psychobiology Research Center (CPRC)18 were interviewed 
using the Schedule for Affective Disorders and Schizophrenia life time 
version (SADS-L), and met the diagnostic criteria for depression with a 
seasonal winter pattern.19 An equal number of healthy volunteers 
paired according to gender, age (range of 2 years) and phase of 
menstrual cycle at the time of the MRI scans were included. The 
depressive symptoms were assessed by a psychiatrist (A.M.S.) using 
the Structured Interview Guide for the Hamilton Depression Rating 
Scale – Seasonal Affective Disorder Version (SIGH-SAD),20 and a 
minimum total score of 15 was required for inclusion in the study. 
The patients had been free of psychotropic medication or hormonal 
treatment for at least three weeks, except for one who had been 
using clonazepam for a long time. The healthy volunteers were 
recruited by advertisement placed at the Paulista School of Medicine. 
They underwent medical history, physical examination, besides the 
SADS-L interview. None of them used any kind of medication or 
had mental or physical illnesses. All patients and healthy volunteers 
were included in the study after signing an informed consent form. 
The study had previously been approved by the Medical Ethics 
Committee of Universidade Federal de São Paulo.
1. Magnetic resonance imaging 
All MRI pituitary scans were run at the Albert Einstein Hospital 
in São Paulo on a 1.5 Tesla Philips ACS II unit (Philips Medical 
System Eindhoven, Netherlands) in the winter (July to September) 
and the following summer (January to March) for both groups. The 
patients were re-examined in the winter at a mean period of 4 days 
(SD ± 1.0) after finishing the phototherapy with 10000 lux. These 
exams required no contrast and lasted around 15 minutes each. 
The subject’s head was positioned in a standard quadrature head 
coil with the canthomeatal line perpendicular to the longitudinal axis 
of his/her head, and the laser beam centered on the nasion. The 
MRI protocol consisted of: 1) scout sequences to ensure symmetric 
positioning of the subject’s head; 2) T1 weighed slices in coronal 
views, graphically determined by the sagittal and axial localizers, 
and perpendicular to the bicomissural plane, covering the pituitary 
gland. The scan parameters were three-dimensional fast field echo, 
1.5 mm over contiguous slices with partitions of 0.75 mm thickness 
(slice factor 0.5), a 30/9/30/2 (repetition time/echo time/flip angle/
number of excitations) pulse sequence, a matrix size of 256 x 256, 
and a field of view (FOV) of 160 mm; 3) T1 weighed sagittal slices, 
prescribed from the coronal and axial localizers, centered on the 
gland. The scan parameters were: two-dimensional spin echo with 
a 599/20/90/4 pulse sequence; 2.5 mm noncontiguous slices (slice 
factor 1.1); matrix size 256 x 256 and a 180 mm FOV.
The images were transferred to an independent workstation 
and volumetric measurements were performed with an interactive 
software (Gyroview HR-software Philips Medical System). Volume was 
estimated according to Ashtari’s proposal:21 the regions of interest of 
each coronal slice were outlined using a manual contouring editing 
function, and the area was automatically obtained by computer. 
Thus, the volume was calculated by adding all areas of interest in 
the coronal views, and by multiplying the total area by the section 
thickness (0.75 mm). The volumetric measurements obtained were 
calculated twice by a neuroradiologist (S.K.N.M.), who was blind to 
the subject’s status with a high reliability (r = 0.95, p < 0.05). 
2. Phototherapy
Treatment was morning exposure to bright light (10000 lux) 
versus lower intensity light (2500 lux) as a control during a 30-
minute period in a double blind crossover fashion. The light source 
was a light box (SunRay II, SunBox Company Inc.). The brightness 
was obtained by varying the distance of the subject to the light 
box (45 cm = 10000 lux; 95 cm = 2500 lux), confirmed with a 
Gossen photometer (LUNA-PRO)®. Patients were randomized and 
rated blindly with the SIGH-SAD before and after each phase of 
the phototherapy.
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 Seven of them underwent treatment at the Clinical Psychobiology 
Research Center (CPRC) between 6:30 and 8:30 AM during a week 
in each treatment phase, with an interval of one week between 
treatments. These patients slept at the CPRC the night before exposure 
to bright light in order to avoid exposure to sunlight, and control time 
and duration of treatment. Two patients who were unable to sleep at 
the CPRC were advised by a team’s member (M.L.N.P.) to undergo 
treatment at home. 
3. Statistical analysis 
Volumetric measures were analyzed with a repeated analysis of 
variance with diagnosis (patients vs. controls) as group factor and 
season (winter vs. summer) as the repeated factor. The effect of 
phototherapy on pituitary volume was analyzed by Student’s paired 
t-test. The SIGH-SAD scores were analyzed using Friedman’s analysis 
of variance by ranks followed by multiple comparison analysis. The 
correlation between variables was assessed with Pearson product 
moment coefficient. P value ≤ 0.05 was considered significant. 
Results 
1. Characteristics of the subjects
The SAD patients were 7 women (58.3%) and 5 men (41.6%), 
and their mean age was 43.4 ± 9.6 years (ranging from 28 to 59). 
This group of patients comprised: 5 patients with major depression 
(2 women, 3 men); 3 subjects with bipolar I disorder (1 woman, 2 
men); and 4 women with bipolar II disorder. None of them had received 
a diagnosis of SAD or had been treated with phototherapy in the past, 
but half of them had previous pharmacological treatment for depression 
without therapeutic response. The mean SIGH-SAD total score at 
the beginning of the study was 25.0 ± 6.4, ranging from 17 to 38 
(Table 1). The mean age of healthy subjects was 42.9 ± 9.4. 
2. Magnetic resonance imaging
Twelve patients with SAD and 12 paired controls were MRI scanned 
in winter and none of them had pituitary cyst or adenoma. Three 
female patients and their matched controls were examined during the 
follicular phase, another three during their luteal phase, and one in post 
menopause. One female patient refused to return for her summer scan. 
Therefore, the MRI data obtained from her and her matched control 
were excluded from the summer analysis. 
The mean ± SD pituitary volumes for control subjects in winter 
and summer were 620.3 ± 130.5 mm3 and 635.2 ± 146.2 mm3, 
respectively. Measures obtained in winter and summer for SAD 
patients were 669.2 ± 125.0 mm3 and 657.5 ± 96.5 mm3, 
respectively. The ANOVA showed no main diagnosis effect 
(F(1,20) = 0.48, p = 0.5), season (F(1,20) = 0.01, p = 0.9) or 
interaction (F(1,20) = 0.68, p = 0.4) as shown in Table 2.  
3. Phototherapy
Four patients refused to be treated with phototherapy. Thus, 
only 8 patients (3 women and 5 men) completed both phases 
of the light treatment protocol. After they were randomized, 6 of 
them began the treatment with 10000 lux (patients 1, 2, 4, 5, 
6 and 7) and 2 (patients 8 and 9) with 2500 lux (Table 3). The 
Friedman’s analysis of variance by ranks revealed a significant 
difference between the phases of treatment (p = 0.004). The 
multiple comparison analysis reveled that the SIGH-SAD scores 
before each phase of the treatment did not differ, but exposure 
to 10000 lux induced a significant reduction in the SIGH-SAD 
scores (22.5 ± 8.7 vs. 10.5 ± 5.1; p < 0.01), whereas lower 
intensity light (2500 lux) had no significant effect on depressive 
symptoms (17.6 ± 7.5 vs. 11.5 ± 4.0; NS) - Table 3.
Data from 8 patients submitted to phototherapy with 10000 
lux did not reveal an effect of light exposure on the pituitary 
volume (668.7 ± 136 mm3 vs. 688.7 ± 115 mm3; p = 0.5). 
However, the pituitary volumes before phototherapy (10000 
lux) were positively correlated with the depression severity 
(r = 0.69, p = 0.04). The small sample size did not allow to 
examine such association following age, gender and menstrual 
cycle adjustments.
Discussion 
1. Pituitary measurements 
Due to its excellent anatomical resolution and characterization 
of tissue, MRI is considered the most adequate neuroimaging 
technique for assessment of small structures with great variable 
Mean ± SD  43.4 ± 9.6                                     15.5 ± 3.8     9.5 ± 4.0       25.0 ± 6.4
Median:                                                                16.5              10.5               23
MDD: major depressive disorder
BD I: bipolar disorder with mania
BD II: bipolar disorder with hypomania
Patients (12) 43.4 ± 9.6 669.2 ± 125.0 657.5 ± 96.5
Healthy subjects (12) 42.9 ± 9.4 620.3 ± 130.5 635.2 ± 146.2
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shape, such as the pituitary gland.22 The volume of the pituitary 
changes during life, and these anatomic changes are believed to 
reflect the functional status of the gland. MRI studies of the pituitary 
gland have demonstrated a sudden growth during puberty23 and a 
gradual decrease with age over adulthood.24,25 Women tend to have 
larger glands than men, with additional transient increases during 
pregnancy and early postpartum period.26-28
The results of the present study show no group mean differences 
in the pituitary volume between patients with SAD and healthy 
volunteers in winter or summer. These findings are in agreement 
with those reported by Schwartz et al.,17 describing similar results 
of pituitary size in patients with SAD. Thus, the lack of enlargement 
of the pituitary volume might distinguish patients with SAD from 
those with major depression. Besides that, this result also suggests 
a lack of hyperactivity of the HPA axis as shown before.29 
A positive correlation between the severity of depressive 
symptoms and the pituitary volume has been found. Although 
this finding should be considered as preliminary due the small 
number of patients studied, it might suggest that most severe 
depressive symptoms could be associated with increased 
dysfunction of the HPA axis, thus influencing the structural 
anatomy of involved organs. Consequently, it might be speculated 
that a significant difference of the pituitary size in patients with 
SAD and healthy volunteers would depend on the severity of the 
depressive symptoms or other characteristics of the disease. To 
our knowledge, there is only one study on winter depression that 
evaluated this association, but it has not demonstrated a significant 
correlation between pituitary volume and severity of depression in 
those patients.17 There are several limitations in interpreting the 
findings of MRI scans in our study. The intracranial volume has 
been measured as well as the laterality of the subjects. In addition, 
similarly to a previous study with SAD patients,17 we evaluated a 
small sample with heterogeneous diagnosis, without separating 
the subjects with bipolar or unipolar disorders. Regarding this 
aspect, an MRI study on nonseasonal affective disorders has 
shown that patients with bipolar disorder had significantly smaller 
pituitary volume than healthy volunteers and patients with unipolar 
depression, but no differences were found between patients with 
unipolar depression and control subjects. However, those with 
bipolar disorders were using lithium during the MRI scans, a 
potentially confounding variable.30 In our study, the SAD bipolar 
patients had never used lithium. 
2. Response to treatment and changes in pituitary volume
Two studies in patients with winter depression assessed the effects 
of phototherapy on cerebral blood flow. Murphy et al.31 submitted 
4 patients with winter depression to single-photon emission 
computerized tomography (SPECT) examination, and showed an 
increased percentage of blood flow in frontal and parietal cortex after 
a single exposure to light (1500 lux) during a two-hour period, in 
comparison with healthy subjects undergoing the same experimental 
procedure. Later, Vasile et al.32 examined the cerebral blood flow of 
10 patients with SAD before and after phototherapy, and reported 
an increase of cerebral blood flow only in those patients having who 
had responded to the treatment. Although these studies have a small 
number of patients, their findings suggest that phototherapy could 
modify the function and/or the anatomy of cerebral or glandular 
structures as shown to occur with pharmacotherapy of patients 
with major depressive disorder.33 In our study, phototherapy with 
10000 lux has not significantly changed volume measures, perhaps 
because the duration of exposure to bright light was brief and thus 
insufficient to produce structural changes.
3. Bright light treatment
This controlled phototherapy study carried out in a tropical area 
(latitude 23.39° S), where differences in photoperiod across the 
seasons are not as pronounced as in temperate zones, was effective. 
Its significant therapeutic effect was only observed after morning 
exposure to the more intense light (10000 lux). Interestingly, all 
patients who were treated with 10000 lux in the first or second 
phase of the crossover had reduction of their depressive symptoms. 
However, the treatment with 2500 lux in the same conditions 
induced an increase of the depressive symptoms in three patients 
(1, 4 e 5) during the second phase of the treatment. These results 
corroborate previous reports, showing that intensity and duration 
of exposure are important factors in the mechanism of action of 
phototherapy.34-36 In addition, the efficacy of phototherapy with 
a bright light (10000 lux) during a 30-minute period adds the 
advantage of reducing the time of exposure to light, making it more 
practical and acceptable to patients.37
Conclusions
Our results suggest that neither winter depression nor the change of 
seasons is associated with significant change in the pituitary volume. 
This study also confirms the occurrence of SAD in tropical latitudes 
and the efficacy of phototherapy as an alternative therapeutic tool 
for winter depressive disorders even in countries with small seasonal 
photoperiodic variations and high luminosity like Brazil. Therefore, 
future studies with larger samples, direct endocrine measures, 
evaluation of seasonality, homogenous samples of patients according 
to diagnosis (bipolar or unipolar disorders) and their state at the 
time of the MRI scan (euthymia or acutely depressed) are needed 
to clarify the differences between seasonal and major depression. 
In addition, adopting standard approaches to light therapy’s specific 
issues (e.g., defining parameters of active vs. placebo conditions), 
and incorporating rigorous designs are necessary to evaluate light 
therapy for winter depression in the Southern Hemisphere.
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